PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 203 filers reported holding PDL BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is 2.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,101,000 | +19.8% | 666,925 | +10.6% | 0.00% | 0.0% |
| Q2 2020 | $1,754,000 | -2.7% | 602,936 | -5.7% | 0.00% | 0.0% |
| Q1 2020 | $1,802,000 | -39.1% | 639,091 | -29.9% | 0.00% | 0.0% |
| Q4 2019 | $2,959,000 | +42.3% | 911,858 | -5.3% | 0.00% | 0.0% |
| Q3 2019 | $2,079,000 | -31.4% | 962,532 | -0.3% | 0.00% | 0.0% |
| Q2 2019 | $3,032,000 | -34.6% | 965,447 | -22.6% | 0.00% | -50.0% |
| Q1 2019 | $4,639,000 | -10.1% | 1,247,043 | -29.9% | 0.00% | 0.0% |
| Q4 2018 | $5,162,000 | +25.0% | 1,779,928 | +13.3% | 0.00% | +100.0% |
| Q3 2018 | $4,131,000 | +15.2% | 1,570,557 | +2.5% | 0.00% | 0.0% |
| Q2 2018 | $3,587,000 | -20.2% | 1,532,880 | +0.3% | 0.00% | -50.0% |
| Q1 2018 | $4,494,000 | +216.5% | 1,528,654 | +195.0% | 0.00% | +100.0% |
| Q4 2017 | $1,420,000 | -76.6% | 518,274 | -71.1% | 0.00% | -50.0% |
| Q3 2017 | $6,076,000 | +15.5% | 1,792,379 | -15.8% | 0.00% | 0.0% |
| Q2 2017 | $5,259,000 | -2.9% | 2,129,184 | -10.7% | 0.00% | 0.0% |
| Q1 2017 | $5,414,000 | +12.1% | 2,385,448 | +4.8% | 0.00% | 0.0% |
| Q4 2016 | $4,828,000 | -43.3% | 2,277,053 | -10.5% | 0.00% | -33.3% |
| Q3 2016 | $8,519,000 | -6.4% | 2,543,010 | -12.3% | 0.00% | 0.0% |
| Q2 2016 | $9,101,000 | -12.4% | 2,898,520 | -7.1% | 0.00% | -25.0% |
| Q1 2016 | $10,387,000 | -4.1% | 3,119,580 | +2.0% | 0.00% | 0.0% |
| Q4 2015 | $10,832,000 | -53.8% | 3,059,760 | -34.3% | 0.00% | -60.0% |
| Q3 2015 | $23,443,000 | -16.3% | 4,660,314 | +7.0% | 0.01% | -9.1% |
| Q2 2015 | $28,000,000 | -6.5% | 4,354,603 | +2.3% | 0.01% | -8.3% |
| Q1 2015 | $29,949,000 | +8.5% | 4,257,268 | +18.9% | 0.01% | +9.1% |
| Q4 2014 | $27,605,000 | +44.4% | 3,580,540 | +39.9% | 0.01% | +37.5% |
| Q3 2014 | $19,119,000 | -36.7% | 2,559,427 | -18.0% | 0.01% | -33.3% |
| Q2 2014 | $30,222,000 | +11.9% | 3,122,197 | -3.9% | 0.01% | +9.1% |
| Q1 2014 | $27,003,000 | +27.2% | 3,249,417 | +29.2% | 0.01% | +37.5% |
| Q4 2013 | $21,226,000 | +42.0% | 2,514,877 | +34.1% | 0.01% | +33.3% |
| Q3 2013 | $14,949,000 | +47.1% | 1,875,542 | +42.5% | 0.01% | +20.0% |
| Q2 2013 | $10,162,000 | – | 1,316,424 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |